Day: June 20, 2024

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

PALO ALTO, Calif., June 20, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that in anticipation of selling our commercially available products to new and current special customers, Scilex has entered into a non-exclusive distribution agreement with a well-known and highly respected distributor with over 10 years of sales excellence, Endeavor Distribution LLC. (“Endeavor”). Endeavor has logistics expertise to sell and distribute our currently marketed non-opioid products nationally. Endeavor is an Oklahoma-owned and operated company committed to top-notch logistics and distribution service. They have...

Continue reading

Mullen CEO Shares Recent Milestones with Committed Capital of $250M; Highlights Include 2 State Incentive Approvals for Class 3 EV Trucks, Commercial Sales and Technology Advancements and Dealer Network Expansion

Company has committed capital in excess of $250 million Fleet customer pipeline includes Yale University, Princeton University, UCLA, Enterprise Fleet Services, DB Schenker and Mobile Road Service Solutions, a AAA provider The Company is also planning to deploy vehicles to Canada with key prospective partners including a major telecom company, which has already tested vehicle telematics with Mullen Mullen’s Class 1 EV cargo van with solid-state polymer battery pack with significant improvement to range will be fully certified for production and sale in second half of 2025 Company in current talks to acquire EV OEMs to expand product portfolio for commercial and passenger EVs Mullen to obtain over-the-air (OTA) vehicle technology powered by AI, along with other related IP assets as part of a successful acquisition BREA, Calif., June 20,...

Continue reading

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building survey. The report, which surveyed over 1,100 LGBTQ+ individuals in the U.S. planning to build their families, highlights the unique challenges LGBTQ+ patients face, including struggles with insufficient access to care, financial constraints, and lack of mental health support throughout their family building journey. Progyny’s survey underscores the pivotal role employers can play in providing inclusive and comprehensive family building benefits that support all paths to parenthood. The findings highlight that employers can significantly improve the lives of LGBTQ+ employees by providing extensive support and resources...

Continue reading

TEN, Ltd. Reports Profits for the First Quarter 2024 and Sets Date for First Common Share Semi-Annual Dividend of $0.60

Dividend doubles from amount paid at same time last year Significant fleet renewal – increased sale & purchase and newbuilding activity since beginning of 2024 Green initiative on target – Six Dual-Fuel LNG vessels fully operational New NYSE Ticker Symbol “TEN” effective July 1st, 2024 Tanker market fundamentals remain solid ATHENS, Greece, June 20, 2024 (GLOBE NEWSWIRE) — TEN, Ltd (TEN) (NYSE: TNP) (the “Company”) today reported results (unaudited) for the quarter ended March 31, 2024. Q1 2024 SUMMARY RESULTSThe first quarter of 2024 has been the springboard for TEN’s green drive with a series of vessel renewals and future growth initiatives. During this time, the fleet averaged almost two vessels fewer than in the equivalent 2023 period and had eight vessels undergoing scheduled drydockings and repairs compared...

Continue reading

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

WORCESTER, Mass., June 20, 2024 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that it has entered into a definitive agreement for the issuance and sale of an aggregate of 6,130,000 of its shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.41 per share (or common stock equivalent in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, Mustang has also agreed to issue and sell unregistered warrants to purchase up to an aggregate of 6,130,000 shares of its common stock. The offering is expected to close on...

Continue reading

WISeKey Announces Creation QUANTIX EDGE SECURITY Joint Venture with SEALSQ, ODIN Solutions, and TProtege

WISeKey Announces Creation QUANTIX EDGE SECURITY Joint Venture with SEALSQ, ODIN Solutions, and TProtege Creates an innovative Cybersecurity and Semiconductor Customization Center, currently in advanced negotiations for PERTE Chip funding with the Spanish Government Geneva, Switzerland / Murcia, Spain – June 20, 2024: In a strategic move that establishes a new milestone in the global cybersecurity and semiconductor landscape, WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY) and its subsidiary SEALSQ Corp (“SEALSQ”) (NASDAQ: LAES), leaders in cybersecurity, artificial intelligence (AI), blockchain, semiconductors, PKI, and post-quantum technology, announced today the signing of an agreement with ODIN Solutions (“ OdinS”) and TProtege, leading companies in Internet of Things (IoT) and security, to create a...

Continue reading

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

AD04 reduced heavy drinking days among heavy drinking individuals with alcohol use disorder and a specific genetic profile, as identified by a companion diagnostic test (CDx) GLEN ALLEN, Va., June 20, 2024 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the publication of previously disclosed results from its Phase 3 ONWARD study in a peer-reviewed article in the European Journal of Internal Medicine entitled, “Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol use disorder endophenotypes.” The publication findings showed a significant difference in the monthly percentage of heavy drinking days between the...

Continue reading

Kearny Financial Corp. Names Chief Operating Officer and Chief Financial Officer

FAIRFIELD, N.J., June 20, 2024 (GLOBE NEWSWIRE) — Kearny Financial Corp. (NASDAQ GS: KRNY) (the “Company”), the holding company for Kearny Bank (the “Bank”), announced today that the Board of Directors promoted Keith Suchodolski to Senior Executive Vice President and Chief Operating Officer, effective July 1, 2024. Mr. Suchodolski has held progressive leadership roles within the Company since 2013, most recently serving as Chief Financial Officer since July 2018. In his new role, Mr. Suchodolski’s range of responsibilities will broaden to include strategic oversight of retail & business banking, human resources, marketing, corporate finance and corporate administration. Craig L. Montanaro, President and Chief Executive Officer said, “Keith is an accomplished leader with a track record of success throughout his time with the...

Continue reading

Microbot Medical Partners with Brigham and Women’s Hospital for Its Pivotal Human Clinical Trial

Following FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient Enrollment Advances Multiple Robotic Systems Already Received by the Site to Allow Inventory Readiness in Support of Trial BRAINTREE, Mass., June 20, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced its agreement with Brigham and Women’s Hospital (BWH), a leading academic medical center located in Boston, Massachusetts, to serve as one of the sites to perform the pivotal human clinical trial for its LIBERTY® Endovascular Robotic Surgical System, as part of its Investigational Device Exemption (“IDE”) application. This development, previously announced on June 17, 2024, follows the U.S. Food and Drug Administration’s approval to commence Microbot’s pivotal human clinical trial. The Company...

Continue reading

Sezzle Authorizes New $15 Million Stock Repurchase Program

Minneapolis, MN, June 20, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, today announced that the Company’s Board of Directors (the “Board”) has authorized the repurchase of an additional $15.0 million of the Company’s common stock after completing its $5.0 million stock repurchase plan announced on December 22, 2023. The manner, timing and amount of any purchase will be based on an evaluation of market conditions, stock price and other factors. “Our confidence in the Company’s continued momentum allows the Board to authorize a new $15 million stock repurchase program,” stated Charlie Youakim, Sezzle Chairman and CEO. “We remain committed to maximizing shareholder value through a disciplined capital allocation policy that will drive growth and maintain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.